Coronary Artery Disease

Clinical Trial Finder

Many patients with coronary artery disease are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Atherosclerosis in Familial Hypercholesterolemia

Condition:   Familial Hypercholesterolemia
Intervention:   Other: CT coronary angiogram and carotid ultrasound
Sponsor:   University College, London
Recruiting - verified July 2015

Treatment of Coronary ARtery bIfurcation Narrowing by AXxess Stent Implantation

Condition:   Coronary Artery Disease
Intervention:   Device: AXXESS stent
Sponsor:   Clinica Mediterranea
Completed - verified June 2015

Optimal Dose of Acetylsalicylic Acid After Coronary Artery Bypass Grafting

Condition:   Stable Coronary Artery Disease With Coronary Artery Bypass Grafting
Intervention:   Drug: Acetylsalicylic acid
Sponsors:   Karolinska University Hospital;   Karolinska Institutet
Active, not recruiting - verified June 2015

Medtronic Polymer-Free Drug-Eluting Coronary Stent System

Condition:   Coronary Artery Disease
Intervention:   Device: Polymer-free DES (Drug Eluting Stent)
Sponsor:   Medtronic Vascular
Not yet recruiting - verified June 2015

Trial to Compare FFR Measurement With a Non-Side-Hole Guide Catheter Vs. a Side-Hole Guide Catheter

Condition:   Coronary Artery Disease
Intervention:   Other: FFR Measurement
Sponsor:   North Texas Veterans Healthcare System
Recruiting - verified June 2015

The Effect of Bikram Yoga on Arterial Stiffness and Endothelial Function in Middle-Aged Adults

Condition:   Aging
Interventions:   Behavioral: Hot yoga;   Behavioral: Non-heated yoga
Sponsor:   University of Texas at Austin
Recruiting - verified June 2015

Comparison of Ticagrelor vs. Prasugrel on Inflammation, Arterial Stiffness, Endothelial Function, and Circulating Endothelial Progenitor Cells in Diabetic Patients With Non-ST Elevation Acute Coronary Syndrome (NSTE-ACS) Requiring Coronary Stenting

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Ticagrelor;   Drug: Prasugrel
Sponsors:   Korea University Anam Hospital;   AstraZeneca
Not yet recruiting - verified June 2015

The Risk of Major Bleeding With Novel Anti-platelets: A Comparison of Ticagrelor With Clopidogrel in a Real World Population of 5000 Patients Treated for Acute Coronary Syndrome

Conditions:   Acute Coronary Syndrome;   Bleeding;   Novel Anti-platelets;   Ticagrelor;   Clopidogrel
Intervention:   Drug: Ticagrelor
Sponsors:   Aintree University Hospitals NHS Foundation Trust;   Liverpool Heart and Chest Hospital NHS Foundation Trust;   Royal Liverpool and Broadgreen University Hospitals NHS Trust;   Countess of Chester NHS Foundation Trust;   St Helens & Knowsley Teaching Hospitals NHS Trust
Recruiting - verified June 2015

CER-001 Atherosclerosis Regression ACS Trial

Condition:   Acute Coronary Syndromes
Intervention:   Drug: CER-001
Sponsors:   Cerenis Therapeutics, SA;   South Australian Health and Medical Research Institute
Not yet recruiting - verified June 2015

OCT-Features in Culprit and Not Culprit Coronary Plaque in ACS Patients

Conditions:   Acute Coronary Syndrome;   Culprit Plaque;   Non Culprit Plaque
Intervention:   Other: optical coherence tomography
Sponsor:   Azienda Ospedaliera Città della Salute e della Scienza di Torino
Recruiting - verified June 2015

The Effects of Journaling on Health-Related Mood and Clinical Outcomes in Post-MI Patients

Conditions:   Myocardial Infarction;   Psychosocial Factors
Interventions:   Behavioral: Gratitude Journaling Plus SOC;   Behavioral: Memorable Events Journaling Plus SOC
Sponsors:   University of California, San Diego;   San Diego Veterans Healthcare System
Enrolling by invitation - verified May 2015

Effectiveness of Advanced Practice Nurse-Led Telehealth on Readmissions

Conditions:   Acute Myocardial Infarction;   Acute Coronary Syndrome
Intervention:   Other: APN-led Telemedicine
Sponsors:   National University Heart Centre, Singapore;   National University Hospital, Singapore
Not yet recruiting - verified June 2015

Clinical Risk Score Predicting the Cardiac Rupture in Patients With ST-elevation Myocardial Infarction

Condition:   Cardiac Rupture
Intervention:   Other: Grouping by different risk stratification
Sponsor:   Chinese PLA General Hospital
Completed - verified May 2015

Understanding Liver Fat Metabolism: Studies to Understand the Role of Dietary Sugars on Liver Fat Metabolism

Condition:   Hypertriglyceridaemia
Intervention:   Other: Sugar study
Sponsor:   University of Oxford
Recruiting - verified June 2015

Impact of Care Transition on Medication Adherence in Cardiac Patients

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   King's College London
Not yet recruiting - verified June 2015

Acute Vascular Response to Exercise in Women With Nonobstructive Coronary Artery Disease

Condition:   Nonobstructive Coronary Artery Disease
Intervention:   Other: Slow-paced walking
Sponsor:   University of Florida
Recruiting - verified June 2015

A Prospective, Single-Blinded, Multi-Center, Randomized, Controlled, Registered Clinical Trial on the Efficacy and Safety of Sirolimus-Eluting Stent (MiStent® System) in the Treatment of Patients With Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Device: MiStentTM;   Device: TIVOLI
Sponsors:   Micell Technologies;   Hefei Life Science Medical Instruments Co. Ltd.;   Giant Med-Pharma Services Inc.;   CCRF Consulting Co., Ltd.
Not yet recruiting - verified June 2015

mWELLCARE:An Integrated mHealth System for the Prevention and Care of Chronic Disease

Conditions:   Hypertension;   Diabetes;   Depression;   Alcohol Abuse
Interventions:   Other: mWELLCARE;   Other: Usual Care
Sponsors:   Public Health Foundation of India;   Wellcome Trust;   London School of Hygiene and Tropical Medicine
Not yet recruiting - verified June 2015

The Combined Portfolio Diet and Exercise Study

Conditions:   Cardiovascular Diseases;   Hypercholesterolemia;   Type 2 Diabetes;   Metabolic Syndrome
Interventions:   Behavioral: Portfolio Plus Diet;   Behavioral: DASH-like (high fiber) Diet
Sponsors:   St. Michael's Hospital, Toronto;   Canadian Institutes of Health Research  (CIHR);   University of Toronto;   Laval University;   University of Manitoba;   University of British Columbia
Not yet recruiting - verified June 2015

Effects of Ivabradine in Patients With Stable Coronary Artery Disease Without Clinical Heart Failure

Condition:   Coronary Artery Disease.
Interventions:   Drug: Ivabradine;   Drug: Placebo
Sponsor:   Servier
Completed - verified June 2015

Quality Measurement and Improvement Study of Surgical Coronary Revascularization: Medication Adherence

Conditions:   Coronary Artery Bypass Grafting;   Medication Adherence;   Mobile Applications
Intervention:   Behavioral: APP intervention
Sponsor:   China National Center for Cardiovascular Diseases
Recruiting - verified June 2015

A Study of CSL112 in Healthy Adults and in Adults With Moderate Renal Impairment

Condition:   Acute Myocardial Infarction
Interventions:   Biological: CSL112;   Other: Placebo
Sponsor:   CSL Behring
Recruiting - verified June 2015

Pain Management After Cardiac Surgery - Opioids or NSAID

Conditions:   Postoperative Pain;   Renal Insufficiency;   Myocardial Infarction
Interventions:   Drug: Ibuprofene;   Drug: Oxycodone
Sponsor:   Aalborg Universitetshospital  
Completed - verified June 2015

An Observational Prospective Study to Understand the Usage Pattern of Ticagrelor With ACS (Acute Coronary Syndrome)

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified June 2015

Affordability and Real-world Antiplatelet Treatment Effectiveness After Myocardial Infarction Study

Condition:   Cost Sharing, Acute Coronary Syndrome,
Intervention:   Other: Study voucher card
Sponsors:   AstraZeneca;   Duke Clinical Research Institute
Recruiting - verified June 2015

Brilinta Taiwan Post Approval Safety Study

Condition:   Non ST-elevation Myocardial Infarction
Intervention:   Drug: Ticagrelor 180mg loading dose taken orally, followed by 90mg twice daily (bd)
Sponsor:   AstraZeneca
Recruiting - verified June 2015

High Fidelity Simulation vs Standard Teaching Training of Cardiac Resuscitation

Condition:   Cardiac Arrest
Interventions:   Device: Laerdal®;   Behavioral: huma patient based training;   Behavioral: traditionally teaching
Sponsor:   University of Monastir
Recruiting - verified June 2015

Study Comparing the MiStent SES Versus the XIENCE EES Stent

Condition:   Coronary Stenosis
Interventions:   Device: MiStent;   Device: XIENCE EES
Sponsors:   ECRI bv;   Micell Technologies;   Stentys
Recruiting - verified June 2015

Ebola CVD-Mali #2000 (Bivalent) VRC-EBOAdc069-00-vp (cAd3-EBO)

Conditions:   Ebola Virus Disease;   Hemorrhagic Fever
Interventions:   Biological: VRC-EBOADC069-00-vp;   Biological: VRC-EBOADC069-00-vp;   Biological: MVA-EbolaZ;   Other: Placebo
Sponsors:   University of Maryland;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified February 2015

Fractional Flow Reserve Versus Angiography Randomization for Graft Optimization Trial

Conditions:   Coronary Artery Disease;   Coronary Disease;   Myocardial Ischemia;   Arteriosclerosis;   Cardiovascular Diseases
Interventions:   Procedure: Fractional flow reserve-guided CABG;   Procedure: Angiography-guided CABG
Sponsor:   Odense University Hospital
Recruiting - verified June 2015

Patient and Provider Assessment of Lipid Management Registry

Conditions:   Hyperlipidemia;   Hypercholesterolemia;   Cardiovascular Disease;   Diabetes;   Chronic Kidney Disease (CKD);   Hypertension;   Smoking;   Myocardial Infarction (MI);   Unstable Angina;   Angina;   Coronary Artery Disease (CAD);   Stroke;   Transient Ischemic Attack (TIA);   Carotid Stenosis;   Peripheral Arterial Disease;   Atherosclerosis;   Claudication
Intervention:  
Sponsors:   Duke University;   Regeneron Pharmaceuticals;   Sanofi
Recruiting - verified June 2015

Screening for Chronic Obstructive Pulmonary Disease in Patients With Acute Coronary Syndromes

Conditions:   Chronic Obstructive Pulmonary Disease;   Acute Coronary Syndromes
Intervention:   Other: screening test
Sponsor:   University Hospital of Ferrara
Active, not recruiting - verified July 2015

BIO monitorinG in Patients With Preserved Left ventricUlar Function AfteR Diagnosed Acute Myocardial Infarction

Condition:   Acute Myocardial Infarction
Intervention:   Device: BioMonitor
Sponsor:   Biotronik SE & Co. KG
Recruiting - verified June 2015

A Study of VentriGel in Early and Late Post-myocardial Infarction Patients

Conditions:   Myocardial Infarction;   Heart Failure;   Left Ventricular Remodeling
Intervention:   Biological: VentriGel
Sponsor:   Ventrix, Inc.
Not yet recruiting - verified June 2015

Axetis Inert Coronary Stent System First In Man Clinical Investigation (AXETIS FIM)

Condition:   Native Coronary Artery Stenosis
Intervention:   Device: Axetis Inert Coronary Stents
Sponsor:   Axetis AG
Recruiting - verified June 2015

RuSsian RegisTry of Acute CoronaRy SyndromE TreAtMent and Approach in Dual Antiplatelet Therapy

Condition:   Acute Coronary Syndrome
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified June 2015

A Phase 2 Trial of AMI MultiStem® Therapy in Subjects With Non-ST Elevation Acute Myocardial Infarction

Conditions:   Heart Attack;   NSTEMI
Interventions:   Biological: AMI MultiStem cells;   Other: Sham
Sponsors:   Athersys, Inc;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified July 2015

Utilization of Ticagrelor in the Upstream Setting for Non-ST-Segment Elevation Myocardial Infarction (UPSTREAM): An ED-Based Clinical Registry

Condition:   Acute Coronary Syndromes
Intervention:   Other: Non-Interventional Study
Sponsor:   AstraZeneca
Recruiting - verified June 2015

Study of a Quality Improvement Toolkit in Kerala, India, Among Hospitals Treating Acute Coronary Syndrome Patients

Condition:   Acute Coronary Syndrome
Intervention:   Behavioral: Quality Improvement Toolkit
Sponsors:   Northwestern University;   National Heart, Lung, and Blood Institute (NHLBI)
Recruiting - verified June 2015

Canola-Mediterranean Diet Study in T2DM

Conditions:   Type 2 Diabetes;   Obesity;   Overweight;   Cardiovascular Diseases
Interventions:   Behavioral: A canola oil enriched mediterranean diet;   Behavioral: A high wheat fiber diet
Sponsors:   St. Michael's Hospital, Toronto;   University of Toronto;   Laval University;   University of Manitoba;   Canola Council of Canada
Recruiting - verified June 2015

Influence of Morphine on Pharmacokinetics and Pharmacodynamics of Ticagrelor in Patients With Acute Myocardial Infarction

Conditions:   ST-segment Elevation Myocardial Infarction;   Non-ST-segment Elevation Myocardial Infarction;   VA Drug Interactions [VA Drug Interaction]
Interventions:   Drug: Morphine;   Drug: Placebo;   Drug: Ticagrelor
Sponsor:   Collegium Medicum w Bydgoszczy
Recruiting - verified June 2015

Ethnicity and Onset of Cardiovascular Disease: A CALIBER Study

Conditions:   Abdominal Aortic Aneurysm;   Coronary Heart Disease;   Sudden Cardiac Death;   Intracerebral Haemorrhage;   Heart Failure;   Ischemic Stroke;   Myocardial Infarction;   Stroke;   Peripheral Arterial Disease;   Stable Angina Pectoris;   Subarachnoid Haemorrhage;   Transient Ischemic Attack;   Unstable Angina;   Cardiac Arrest
Intervention:  
Sponsors:   University College, London;   Wellcome Trust;   National Institute for Health Research, United Kingdom;   London School of Hygiene and Tropical Medicine
Active, not recruiting - verified July 2015

Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?

Condition:   Acute Coronary Syndome
Interventions:   Other: Blood Test;   Other: EndoPAT - endothelial assessment
Sponsor:   Jennifer Rossington
Recruiting - verified June 2015

Using Feedback Reports to Improve Medication Adherence

Conditions:   Coronary Artery Disease;   Adherence
Interventions:   Behavioral: Individual Feedback;   Behavioral: Feedback Friend
Sponsor:   Philadelphia Veterans Affairs Medical Center
Recruiting - verified May 2014

Characterization of Changes in Ventricular Mechanics in Response to Lexiscan Stress Using Tagged Cine Cardiac Magnetic Resonance Imaging

Condition:   Coronary Artery Disease
Intervention:   Drug: Regadenoson
Sponsors:   Timothy M. Bateman;   Saint Luke's Health System;   Saint Luke's Cardiovascular Consultants
Recruiting - verified June 2015

A Phase 2b Study of CSL112 in Subjects With Acute Myocardial Infarction.

Condition:   Acute Myocardial Infarction
Interventions:   Biological: CSL112;   Biological: Placebo
Sponsor:   CSL Behring
Recruiting - verified June 2015

Impact of Continuous Positive Airway Pressure (CPAP) Therapy on Outcomes in Patients Undergoing Coronary Revascularization

Conditions:   Obstructive Sleep Apnea;   Ischaemic Heart Desease
Intervention:   Device: CPAP
Sponsor:   Beijing Anzhen Hospital
Recruiting - verified June 2015

Phase I Trial of Endocavitary Injection of Bone Marrow Derived CD133+ Cells in Ischemic Refractory Cardiomyopathy (RECARDIO Trial)

Condition:   Chronic Myocardial Ischemia
Intervention:   Other: Autologous bone marrow derived-CD133+ cells
Sponsors:   Centro Cardiologico Monzino;   Azienda Ospedaliera Città della Salute e della Scienza di Torino;   Azienda Ospedaliera San Gerardo di Monza
Recruiting - verified June 2015

Identification of CETP as a Marker of Atherosclerosis

Condition:   Cardiovascular Disease
Intervention:   Other: cardiovascular risk factors
Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France
Recruiting - verified June 2015

Utilising Lifemap to Investigate Malignant Arrhythmia Therapy

Conditions:   Ischemic Cardiomyopathy;   Sudden Cardiac Death;   Implantable Defibrillator User;   Myocardial Infarction;   Arrhythmias, Cardiac
Intervention:  
Sponsors:   University Hospitals, Leicester;   University of Leicester
Recruiting - verified June 2015

Improving the Quality of Private Sector Health Care in West Bengal

Conditions:   Myocardial Infarction;   Diarrhea (Dysentery);   Asthma
Interventions:   Other: Training;   Other: Control
Sponsors:   Abdul Latif Jameel Poverty Action Lab;   National Rural Health Mission, Government of West Bengal, India;   Liver Foundation, West Bengal;   World Bank
Completed - verified June 2015

Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers.

Conditions:   Ischaemic Heart Disease;   Aortic Stenosis
Interventions:   Drug: Remifentanil;   Drug: Sufentanil
Sponsor:   Aarhus University Hospital
Active, not recruiting - verified June 2015

Ticagrelor vs Clopidogrel in Non-ST Elevation Acute Coronary Syndrome Patients Undergoing PCI With Bivalirudin.

Condition:   Non-ST Elevation Acute Coronary Syndrome
Interventions:   Drug: ticagrelor;   Drug: clopidogrel
Sponsor:   AstraZeneca
Terminated - verified June 2015

Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.

Condition:   Coronary Atherosclerosis and Other Heart Disease
Interventions:   Other: Mononuclear cells from autologous bone marrow;   Drug: Conventional medical treatment
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas 
Recruiting - verified June 2015

Different LD of Ticagrelor for Antiplatelet Effect in Patients With Non-ST-segment Elevation ACS Undergoing PCI

Condition:   Non ST Segment Elevation Acute Coronary Syndrome
Intervention:   Drug: ticagrelor
Sponsor:   General Hospital of Chinese Armed Police Forces
Recruiting - verified January 2015

Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients

Condition:   Hiv Infection
Intervention:   Biological: blood sampling,
Sponsor:   French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
Recruiting - verified June 2015

Ticagrelor and Eptifibatide Bolus-Only Versus Ticagrelor and Eptifibatide Bolus Plus Abbreviated Infusion

Condition:   Acute Coronary Syndrome
Interventions:   Drug: ticagrelor;   Drug: Eptifibatide
Sponsors:   University of Alabama at Birmingham;   AstraZeneca
Active, not recruiting - verified June 2015

Efficacy and Safety Study of Ticagrelor

Condition:   Acute Coronary Syndrome
Interventions:   Drug: Clopidogrel;   Drug: Ticagrelor
Sponsor:   General Hospital of Chinese Armed Police Forces
Recruiting - verified March 2015

Image Content Analysis of Dural-axis Rotational Versus Standard Coronary Angiography

Condition:   Coronary Artery Disease
Intervention:   Procedure: Coronary Angiography
Sponsor:   General Hospital of Chinese Armed Police Forces
Completed - verified June 2015

SILVER-AMI: Outcomes in Older Persons With Heart Attacks

Condition:   Acute Myocardial Infarction
Intervention:  
Sponsors:   Sarwat Chaudhry;   National Heart, Lung, and Blood Institute (NHLBI)
Enrolling by invitation - verified July 2015

A Study to Evaluate the Effect of Aleglitazar on Cardiac Energetics and Function in Patients With Type 2 Diabetes Mellitus and no History of Coronary Artery Disease

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: aleglitazar;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Prospective Characterization of the Heart, Aorta and Blood Pressure in Turner Syndrome. Association With Aortic Dissection.

Conditions:   Turner Syndrome;   Aortic Aneurysm;   Ischemic Heart Disease;   Hypertension;   Congenital Heart Defect
Intervention:  
Sponsor:   University of Aarhus
Recruiting - verified June 2015

X-chromosome Inactivation, Epigenetics and the Transcriptome

Conditions:   Turner Syndrome;   Klinefelter Syndrome;   Triple X Syndrome;   47 XYY Syndrome;   Aortic Aneurysm
Intervention:  
Sponsors:   University of Aarhus;   Lundbeck Foundation;   The Korning Foundation Denmark;   AP Moeller Foundation
Active, not recruiting - verified June 2015

A Phase II Study of the Safety and Efficacy of MPSK3169A in Patients With Coronary Heart Disease or High Risk of Coronary Heart Disease

Condition:   Coronary Heart Disease
Interventions:   Drug: MPSK3169A;   Drug: MPSK3169A;   Drug: MPSK3169A;   Drug: MPSK3169A;   Drug: MPSK3169A;   Drug: Placebo
Sponsor:   Genentech, Inc.
Completed - verified July 2015

A Post Marketing Surveillance to Evaluate the Safety and Efficacy of Brilinta

Condition:   Acute Coronary Syndromes
Intervention:  
Sponsor:   AstraZeneca
Recruiting - verified June 2015

Intracoronary Infusion of Bone Marrow Mononuclear Cells in Patients With Previous Myocardial Infarction.

Condition:   Chronic Myocardial Ischemia
Intervention:   Other: Bone marrow mononuclear cells
Sponsors:   Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud;   Iniciativa Andaluza en Terapias Avanzadas 
Completed - verified November 2014

Treatment With Ranolazine in Microvascular Coronary Dysfunction (MCD): Impact on Angina Myocardial Ischemia

Condition:   Microvascular Coronary Dysfunction (MCD)
Interventions:   Drug: Ranolazine;   Drug: Placebo
Sponsors:   Cedars-Sinai Medical Center;   University of Florida
Recruiting - verified June 2015

A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)

Condition:   Coronary Heart Disease
Interventions:   Drug: dalcetrapib;   Drug: placebo
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Influence of Varenicline on the Antiplatelet Action of Clopidogrel

Condition:   Coronary Artery Disease
Interventions:   Drug: Varenicline;   Behavioral: Counseling and psychosocial support
Sponsor:   General Hospital of Chinese Armed Police Forces
Recruiting - verified April 2015

A Study of RO4905417 in Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery

Condition:   Coronary Heart Disease, Graft Occlusion, Vascular
Interventions:   Drug: Placebo;   Drug: RO4905417
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Efficacy of Topical Capsaicin Cream for Stable Angina

Condition:   Stable Angina
Interventions:   Drug: Capsaicin;   Other: Placebo cream
Sponsors:   Neal Weintraub;   University of Cincinnati
Terminated - verified June 2015

Carpentier-Edwards PERIMOUNT Magna Ease Pericardial Bioprosthesis, Model 3300TFX

Conditions:   Coronary Artery Disease;   Aortic Valve Disorder;   Heart Failure;   Aortic Valve Stenosis;   Aortic Valve Insufficiency
Intervention:   Device: Implantation of CEP Magna Ease Model 3300TFX
Sponsor:   Edwards Lifesciences
Active, not recruiting - verified June 2015

Effects of Amino Acids on Regional Lipid Metabolism

Condition:   Hypertriglyceridemia
Interventions:   Dietary Supplement: Amino acids;   Dietary Supplement: Placebo
Sponsors:   University of Arkansas;   National Institute on Aging (NIA)
Recruiting - verified June 2015

Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPET

Condition:   Coronary Artery Disease
Interventions:   Drug: Exercise plus Regadenoson (Lexercise);   Drug: Regadenoson (Lexiscan)
Sponsor:   Brigham and Women's Hospital
Recruiting - verified June 2015

TomVasc - Vascular Effects of Tomato Extract

Conditions:   Ischemic Heart Disease;   Transient Ischemic Attack;   Stroke;   Peripheral Vascular Disease
Interventions:   Dietary Supplement: Ateronon;   Dietary Supplement: Placebo
Sponsors:   Cambridge University Hospitals NHS Foundation Trust;   Cambridge Theranostics Ltd
Completed - verified July 2012

A Study With Aleglitazar in Patients With a Recent Acute Coronary Syndrome and Type 2 Diabetes Mellitus

Condition:   Diabetes Mellitus, Type 2
Interventions:   Drug: Aleglitazar;   Drug: Placebo
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Transpulmonary Thermodilution Measurements in Patients With Heart Diseases

Condition:   Heart Diseases
Intervention:   Device: PiCCO Catheter (Pulsiocath 5F)
Sponsor:   University of Zurich
Completed - verified June 2015

AngioSculpt Scoring Balloon Catheter For Bifurcation Coronary Lesions (ABC Study)

Condition:   Bifurcation Coronary Disease
Intervention:   Device: AngioSculpt
Sponsor:   HaEmek Medical Center, Israel
Terminated - verified June 2015

BAY81-8781, I.V. Aspirin in the Indication of Acute Coronary Syndrome (ACS)

Condition:   Acute Coronary Syndrome
Interventions:   Drug: D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IV;   Drug: D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 250 mg IV;   Drug: Acetylsalicylic acid (Aspirin, BAYe4465) 300 mg Tablet
Sponsor:   Bayer
Completed - verified June 2015

Renal Function in Patients Submitted to Myocardial Revascularization Surgery

Condition:   Coronary Disease
Intervention:  
Sponsors:   UPECLIN HC FM Botucatu Unesp;   Faculdade de Medicina de Botucatu, UNESP, Botucatu, Brasil;   Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.
Terminated - verified May 2009

Associations Between Diabetes Care and Haptoglobin Genotype On outComes

Conditions:   Diabetes;   Cardiovascular Disease;   Myocardial Infarction;   Stroke
Intervention:  
Sponsor:   Clalit Health Services
Active, not recruiting - verified June 2015

Magna® Mitral Pericardial Bioprostheses Post-Approval Study Protocol

Conditions:   Coronary Artery Disease;   Mitral Valve Regurgitation;   Mitral Valve Incompetence;   Heart Failure
Intervention:   Device: CEP MAGNA MITRAL PERICARDIAL BIOPROSTHESES
Sponsor:   Edwards Lifesciences
Recruiting - verified July 2015

Vytorin on Carotid Intima-media Thickness and Overall Rigidity

Condition:   Cardiovascular Diseases
Interventions:   Drug: ezetimibe (+) simvastatin;   Drug: simvastatin;   Drug: pravastatin
Sponsors:   Hospital Universitario 12 de Octubre;   Merck Sharp & Dohme Corp.
Completed - verified August 2008

An Observational Study of TNKase in Patients Enrolled in the National Registry of Myocardial Infarction 4 and 5 (POST)

Condition:   Acute Myocardial Infarction
Intervention:  
Sponsor:   Genentech, Inc.
Completed - verified April 2008

A Study Assessing the Effect of RO4607381 on Vascular Function in Patients With Coronary Heart Disease (CHD) or CHD-Risk Equivalent Patients

Condition:   Coronary Heart Disease
Interventions:   Drug: Placebo;   Drug: dalcetrapib
Sponsor:   Hoffmann-La Roche
Completed - verified July 2015

Cardiac AResT And GENEtic

Condition:   Out-of-hospital Cardiac Arrest
Intervention:  
Sponsor:   Institut National de la Santé Et de la Recherche Médicale, France
Completed - verified June 2015

ACT34-CMI -- Adult Autologous CD34+ Stem Cells (Follow-Up Study)

Condition:   Myocardial Ischemia
Intervention:  
Sponsor:   Baxalta US Inc.
Completed - verified July 2010

Cardiology Biobank Registry

Condition:   Cardiovascular Disease
Intervention:  
Sponsor:   Emory University
Recruiting - verified June 2015

Inflammatory Response During Anesthesia and Surgery

Conditions:   Systemic Inflammatory Response Syndrome;   Myocardial Ischemia
Intervention:  
Sponsors:   UMC Utrecht;   European Association of Cardiothoracic Anaesthesiologists
Completed - verified June 2008

Vascular Aging: The Link That Bridges Age to Atherosclerosis (The VALIDATE Study)

Conditions:   Atherosclerosis;   Cardiovascular Disease;   Vascular Diseases
Intervention:  
Sponsor:   National Institute on Aging (NIA)
Active, not recruiting - verified May 2015

The BEAUTIFUL Study: Effects of Ivabradine in Patients With Stable Coronary Artery Disease and Left Ventricular Systolic Dysfunction

Conditions:   Coronary Disease;   Ventricular Dysfunction, Left
Interventions:   Drug: Ivabradine;   Drug: Placebo
Sponsor:   Institut de Recherches Internationales Servier
Completed - verified June 2015

Get CardioSmart

You're Invited